Articles From: FARO® announces major release of the world's most popular law enforcement diagramming software - CAD Zone Suite 10; enhancing the user experience with hundreds of new features and animations for Law Enforcement and Public Safety officials. to BMO Announces $1 Million Donation to Smilezone Foundation to Improve Healthcare Facilities for Children


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0971620001&sourceType=1 http://www.ccnmatthews.com/logos/20051013-200.jpg TORONTO, ONTARIO --
Sign-up for Diamond Drilling to Begin Imminently at CBay's Devlin Property in Chibougamau investment picks
http://media.marketwire.com/attachments/201108/10048_CobraLogo-Black.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1136970&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Cobra Electronics Nominated for Channel IQ 2014 Innovation Award for Best Policy Enforcement investment picks
BEIJING , Aug.
Sign-up for TechFaith Reports Second Quarter 2014 Financial Results investment picks
Canada’s long-anticipated Anti-Spam Legislation (CASL) came into effect July 1, ushering in a new era for online marketing.
Sign-up for Canadian Small Businesses Not CASL-Ready According to New Constant Contact Survey investment picks
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it will host a conference call and live audio webcast on Wednesday, August 13, 2014 at 8:00 a.m. ET to report second quarter 2014 financial results and provide a corporate update.
Sign-up for Epizyme, Inc. to Report Second Quarter Financial Results and Provide Corporate Update on August 13, 2014 investment picks
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the appointments of Peter Ho, M.D., Ph.D., as Chief Development Officer and Michael Shih, J.D. as Vice President, Business Development.
Sign-up for Epizyme Appoints Peter Ho, M.D., Ph.D., as Chief Development Officer and Michael Shih, J.D., as Vice President, Business Development investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced second quarter 2014 operating and financial results and reiterated 2014 guidance.
Sign-up for Epizyme Announces Second Quarter 2014 Financial Results and Provides Corporate Update investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, reported pre-clinical data and early clinical observations from an ongoing Phase 1 trial, being conducted in collaboration with Eisai, the Institut Gustave Roussy, and the Institut Bergonie, of EZH2 inhibitor EPZ-6438 (E7438) in patients with advanced solid tumors and B-cell lymphomas.
Sign-up for Epizyme Presents Pre-Clinical Data and Early Clinical Observations from Ongoing Phase 1 Trial of EZH2 Inhibitor EPZ-6438 (E7438) at ASH Meeting on Lymphoma Biology investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that Jason Rhodes, President and Chief Financial Officer, has resigned from the company, effective September 30, 2014.
Sign-up for Epizyme Announces Resignation of President and Chief Financial Officer Jason Rhodes investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in five upcoming conferences in September: About Epizyme, Inc. Epizyme, Inc. is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers.
Sign-up for Epizyme to Present at Upcoming Conferences in September investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in three upcoming events in October: About Epizyme, Inc. Epizyme, Inc. is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers.
Sign-up for Epizyme, Inc. to Present at Upcoming Events in October investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced, in conjunction with its development partner Eisai, that clinical data from the ongoing Phase 1 study of EPZ-6438 (E7438), an oral, small molecule inhibitor of EZH2, will be featured in a late-breaking oral presentation at the 26 th EORTC-AACR-NCI Symposium on Molecular Targets and Cancer Therapeutics, to be held November 18-21 in Barcelona, Spain.
Sign-up for Epizyme Announces Clinical Data from Phase 1 Trial of EZH2 Inhibitor EPZ-6438 (E7438) to be Presented at EORTC-NCI-AACR Symposium investment picks
2014/9/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0969414001&sourceType=1 http://www.ccnmatthews.com/logos2/eh1103.gif MISSISSAUGA, ONTARIO --
Sign-up for easyhome Ltd. Introduces New Masterbrand - goeasy investment picks
- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time - ABSORB IV will compare Absorb to a best-in-class, metallic drug eluting stent in people with coronary artery disease, the most common type of heart disease - Trial will prospectively measure rates of angina, or chest pain, in the first randomized controlled heart stent trial with angina as a primary endpoint to assess impact of angina on healthcare costs and quality of life ABBOTT PARK, Ill., Sept.
Sign-up for Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device investment picks
2014/8/6
MADISON, N.J. , Aug.
Sign-up for CENTURY 21 Real Estate Sweeps J.D. Power 2014 Home Buyer/Seller Satisfaction Study investment picks
As oil and gas production continues to rise in the nation’s top shale formations, On the Move Systems Corp.
Sign-up for OMVS Examines New Revenue Potential in Oil & Gas Trucking investment picks
Global Healthcare Company to Expand into 200,000 Square Feet in 650 East Kendall Street Property CAMBRIDGE, Mass.
Sign-up for BioMed Realty Trust Signs A New 12-Year Lease Establishing New Innovation And R&D Center In Kendall Square In Cambridge, Massachusetts investment picks
2014/7/15
Collection to Deliver the Ultimate Fashion for Every Girl in a Digitally Enhanced Experience NEW YORK , July 15, 2014 /PRNewswire/ -- Hearst Brand Development announced today the exclusive launch of Seventeen Magazine 's fashion collection at Sears .
Sign-up for Seventeen Magazine Fashion Collection To Launch Exclusively At Sears investment picks
Global cinema giant adopts Jive's enterprise communication and collaboration solutions to support staff in providing "luxury cinema" experience PALO ALTO, Calif.
Sign-up for Cinepolis Chooses Jive To Strengthen Collaborative Workstyle And Unify Company Culture Across 27,000 Employees investment picks
2014/9/12
By Frances Robinson And Laurence Norman BRUSSELS--The European Union extended its sanctions on Russia and rebels in eastern Ukraine on Friday, adding 15 companies and 24 individuals to its blacklist and imposing new measures against the country's oil and defense sectors, in an effort to target those dealing with the separatists.
Sign-up for EU Widens Sanctions on Russian Companies, Individuals Over Ukraine Crisis investment picks
2014/10/3
By Frances Robinson BRUSSELS--The European Commission closed an investigation into how some of Europe's biggest telecommunications companies charge content providers for faster, smoother access to their networks for services such as video streaming, though said Friday it would keep a close eye on their practices.
Sign-up for EU Closes Telecoms Investigation but Remains Vigilant investment picks
Heatwurx®, Inc. (OTCQB:HUWX), a premier developer of patented eco-friendly asphalt restoration and permanent repair technology, has begun selling franchises of its service provider, Dr.
Sign-up for Heatwurx® Franchises Dr. Pave Worldwide, LLC’s Asphalt Repair and Restoration Service investment picks
2014/9/23
By Friedrich Geiger BERLIN--Bayer AG has appointed Frank H.
Sign-up for Bayer Names Frank Lutz Chief Financial Officer for Bayer MaterialScience investment picks
2014/10/6
By Friedrich Geiger BERLIN--Siemens AG's (SIE.XE) building technologies division will be headed by its veteran Matthias Rebellius from January, the German engineering group said Monday.
Sign-up for Siemens Names New Chief of Building Technologies Division investment picks
2014/10/7
By Friedrich Geiger BERLIN--Volkswagen AG delivered 534,800 passenger cars with the namesake brand globally in September, a 0.2% increase from a year earlier, the German company said Tuesday.
Sign-up for Volkswagen Brand Car Sales Stagnate in September investment picks
2014/10/2
By Friedrich Geiger BERLIN-RWE AG (RWE.XE) has agreed to sell the buildings in which its headquarters are based in Essen to U.S. property fund American Realty Capital Global Trust Inc., the German utility said Thursday.
Sign-up for RWE Sells Headquarters Buildings in Essen to U.S. Property Fund investment picks
2014/7/15
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0956916003&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://www.marketwire.com/library/20140714-956916aS.jpg Janet Peddigrew, Vice President & Managing Director, Ontario Region, BMO Harris Private Banking (C), presents a $1 million donation to former New York Rangers & Smilezone Foundation Co-founder Adam Graves (L), and Scott Bachly, Smilezone Co-founder (R). http://www.marketwire.com/library/20140714-956916bS.jpg Sportsnet Sportcaster Nick Kypreos; Janet Peddigrew, Vice President & Managing Director, Ontario Region, BMO Harris Private Banking; Hockey Night in Canada's Glenn Healy; Scott Bachly, Smilezone Co-founder; and former New York Rangers & Smilezone Foundation Co-founder Adam Graves at the second annual Celebrity Smilezone
Sign-up for BMO Announces $1 Million Donation to Smilezone Foundation to Improve Healthcare Facilities for Children investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: FARO® announces major release of the world's most popular law enforcement diagramming software - CAD Zone Suite 10; enhancing the user experience with hundreds of new features and animations for Law Enforcement and Public Safety officials. to BMO Announces $1 Million Donation to Smilezone Foundation to Improve Healthcare Facilities for Children
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices